Production and characterization of human T leukemic lymphoblastoid cell interferon. 1982

J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and T Kishida, and J Minowada

Although human lymphoblastoid cells (Namalva and BALL-1 cells) which have the characteristics of B lymphocytes are known to be good producers of human lymphoblastoid interferon (Hu IFN-alpha (Ly) ), there is only one report on IFN production by human T lymphoblastoid cells. The present study showed that Sendai virus could induce human T lymphoblastoid cells (RPMI 8402 cells) to produce IFN. On incubation with virus, IFN was detected after 9 h, and increased until 24 h. The IFN yield depended on the dose of Sendai virus. No superinduction was observed on treatment with BUdR or antimetabolites or on irradiation with ultraviolet light. The T cell line produced IFN even in serum-free medium. The IFN produced by RPMI 8402 cells (8402-IFN) was as stable at pH 2 and on heating at 60 C for 30 min as Hu IFN-alpha and Hu IFN-beta. 8402-IFN, Hu IFN-alpha and Hu IFN-beta showed the same kinetics of induction of the antiviral state of FL cells. The 8402-IFN was neutralized by anti-Hu IFN-beta serum, but not anti-Hu IFN-alpha serum, indicating that it was antigenically identical with Hu IFN-beta. MDBK cells were very sensitive to Hu IFN-alpha, but not to this IFN or Hu IFN-beta, but L929 and RK-13 cells were equally sensitive to 8402-IFN, Hu IFN-alpha and Hu IFN-beta. The molecular weight of this IFN was estimated as 21,000 and 16,500 daltons by SDS-PAGE and Sephadex G-100 gel chromatography, respectively.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D010222 Parainfluenza Virus 1, Human A species of RESPIROVIRUS also called hemadsorption virus 2 (HA2), which causes laryngotracheitis in humans, especially children. Hemadsorption Virus 2,Human parainfluenza virus 1,Para-Influenza Virus Type 1,Parainfluenza Virus Type 1,Para Influenza Virus Type 1
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and T Kishida, and J Minowada
February 1982, Infection and immunity,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and T Kishida, and J Minowada
January 1984, Microbiology and immunology,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and T Kishida, and J Minowada
January 1975, Journal of clinical microbiology,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and T Kishida, and J Minowada
January 1982, International journal of cancer,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and T Kishida, and J Minowada
January 1982, Microbiology and immunology,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and T Kishida, and J Minowada
January 1981, Methods in enzymology,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and T Kishida, and J Minowada
January 1981, The Journal of general virology,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and T Kishida, and J Minowada
December 1980, Cancer treatment reviews,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and T Kishida, and J Minowada
May 1982, The Journal of general virology,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and T Kishida, and J Minowada
July 1974, Journal of the National Cancer Institute,
Copied contents to your clipboard!